Statistics about Health, Pharma & Medtech in United States
Statistics
- Operating income of Celgene corporation 2014-2018
- Home infusion therapy market size by product U.S. 2014-2024
- Top pharmaceutical manufacturer vs. top pharmaceutical distributor U.S. 2019
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
- Projected 2024 revenue for top drugs approved U.S. 2018
- Unbranded generic corporations in U.S. 2017-2018, by absolute dollar growth
- Growing unbranded generic corporations by absolute Rx growth U.S. 2017-2018
- Physicians that received opioid-manufacturer payments in New York 2013-2015
- Drug manufacturer payments to New York physicians 2013-2015, by characteristic
- Publicy reported investments among the top 10 medtech companies 2018
- Value of exports of pharmaceutical products from Spain to USA 2012-2017
- CMS add-on payments proposed for select medical devices 2017
- Market share for medical and surgical hemostats U.S. 2015
- Clinical CRO market share worldwide by company 2016
- Pharmaceutical industry violations in the U.S. 1991-2017, by violation type
- Pharmaceutical industry financial penalties in the U.S. 1991-2017, by violation type
- Pharmaceutical industry financial penalties - United States 1991-2017
- Healthcare patents of technology companies Microsoft, Apple, and Google 2009-2017
- U.S. osteoporosis drug market size from 2014 to 2025, by product
- Key figures on U.S. blood plasma market 2015
- Share of company sales of biggest selling drugs going generic in the U.S. in 2017
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- U.S. market size of propofol 2010-2013
- Highest pharmaceutical company penalties in the U.S. 2012-2015
- U.S. pharmaceutical industry financial penalties - state and federal 1991-2015
- Pharmaceutical industry settlements number - state and federal governments 1991-2015
- Top U.S. states by financial penalties for pharmaceutical companies 1991-2015
- Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Accumulation U.S. costs saved through generic pharmaceuticals 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Saving of U.S. costs through generic cardiovascular pharmaceuticals 2004-2013
- Saving of U.S. costs through generic nervous system pharmaceuticals 2004-2013
- Providing personal information for free health care services or information 2013
- Top five services from pharma companies for U.S. patients 2013
- Satisfaction or desire for received pharmaceutical services in the U.S. 2013
- Preferred services from a pharmaceutical company 2013
- Responsibility of pharmaceutical firms to provide complementary services 2013
- Annual economic burden in the U.S. due to medical technology by area 2008-2010
- Losses in the U.S. from medical technology and decreased incentives 2010-2035
- Savings in the U.S. due to medical technology with increased incentives 2010-2035
- Economic impact in the U.S. due to medical technologies 2008-2010
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
- Percentage of doses patients take as prescribed in the U.S. 2001 by condition
- Number of da Vinci surgical procedures in the United States 2021-2025
- Most significant concerns regarding AI in radiology U.S. 2024
- Concerns about business implications of AI-based tools in radiology U.S. 2024
- Confidence level in the U.S. medical imaging sector Q2 2024, by hospital size
- Confidence level in the U.S. medical imaging sector 2018-2024
- Respiratory devices with potential being modified to ventilators by company 2020
- U.S. cardiac arrhythmia monitoring devices market revenue 2016-2026
- MRI scans number change 2016 vs. 2017 U.S., by facility type
- Preference in robot-assisted or traditional surgery among U.S. adults 2018
- Rate of death/injury events in robot-assisted procedures U.S. 2006-2013
- Rate of adverse events in robot-assisted procedures U.S. 2004-2013
- Costs for laparoscopic vs. robot-assisted radical nephrectomy U.S. 2003-2015
- Events in laparoscopic vs. robot-assisted radical nephrectomy U.S. 2003-2015
- Attitudes on AI in therapy in the U.S. 2026, by generation
- Revenue in the medical devices segment in the United States 2016-2030
- Revenue in the medical technology market in the United States 2016-2030
- Orchestra Biomed Holdings, Inc. liabilities 2021-2025
- Merit Medical Systems total assets 2021-2025
- Nutriband total assets 2021-2025
- Sensus Healthcare total assets 2021-2025
- Spectral Ai, Inc. liabilities 2021-2025
- Marizyme, Inc. total assets 2019-2023
- Teleflex total assets 2021-2025
- Omnia Wellness Inc. total assets 2017-2021
- Helius Medical Technologies, Inc. liabilities 2021-2025
- Electromedical Technologies liabilities 2019-2023
- Adm Tronics Unlimited total assets 2020-2024
- Interpace Biosciences liabilities 2021-2025
- Sharps Technology Inc. total assets 2021-2025
- Accuray liabilities 2021-2025
- Sharps Technology Inc. liabilities 2021-2025
- Lucid Diagnostics liabilities 2021-2025
- Penumbra total assets 2021-2025
- Neuroone Medical Technologies total assets 2021-2025
- Microbot Medical liabilities 2021-2025
- Vivos liabilities 2021-2025
- Dexcom liabilities 2021-2025
- Align Technology liabilities 2021-2025
- Pavmed total assets 2021-2025
- Regenicin, Inc. total assets 2018-2022
- Cutera total assets 2019-2023
- Stryker liabilities 2021-2025
- Invivo Therapeutics Holdings liabilities 2018-2022
- Cvrx liabilities 2021-2025
- Procept Biorobotics liabilities 2021-2025
- Plus Therapeutics, Inc. liabilities 2021-2025
- Irhythm Technologies liabilities 2021-2025
- Lyra Therapeutics liabilities 2021-2025
- Vivani Medical, Inc. liabilities 2020-2025
- HeartSciences Inc. total assets 2021-2024
- Orchestra Biomed Holdings, Inc. total assets 2021-2025
- Procept Biorobotics total assets 2021-2025
- Hologic Inc total assets 2021-2025
- Dror Ortho-Design liabilities 2021-2025
- Pulmonx total assets 2021-2025
- Lucid Diagnostics total assets 2021-2025